{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:49:19Z","timestamp":1649076559051},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00108-014-3622-7","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T07:35:10Z","timestamp":1420788910000},"page":"84-90","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acetylsalicyls\u00e4ure und ven\u00f6se Thrombosen"],"prefix":"10.1007","volume":"56","author":[{"given":"K.","family":"Schr\u00f6r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,11]]},"reference":[{"key":"3622_CR1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","volume":"158","author":"Anderson","year":"2013","unstructured":"Anderson DR, Dunbar MJ, Bohm ER et al (2013) Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 158:800\u2013806","journal-title":"Ann Intern Med"},{"key":"3622_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","volume":"308","author":"Antiplatelet","year":"1994","unstructured":"Antiplatelet Trialists\u2018 Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy. III.\u00a0Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 308:235\u2013246","journal-title":"Br Med J"},{"key":"3622_CR3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5301\/HIP.2012.9058","volume":"22","author":"Aquilina","year":"2012","unstructured":"Aquilina AL, Brunton LR, Whitehouse MR et al (2012) Direct thrombin inhibitor (DTI) vs. aspirin in primary total hip and knee replacement using wound ooze as the primary outcome measure. A prospective cohort study. Hip Int 22:22\u201327","journal-title":"Hip Int"},{"key":"3622_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.blre.2014.03.003","volume":"28","author":"Becattini","year":"2014","unstructured":"Becattini C, Agnelli G (2014) Aspirin for prevention and treatment of venous thromboembolism. Blood Rev 28:103\u2013108","journal-title":"Blood Rev"},{"key":"3622_CR5","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","volume":"366","author":"Becattini","year":"2012","unstructured":"Becattini C, Agnelli G, Schenone A et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959\u20131967","journal-title":"N Engl J Med"},{"key":"3622_CR6","doi-asserted-by":"crossref","unstructured":"Bloch BV, Patel V, Best AJ (2014) Thromboprophylaxis with dabigatran leads to an increased incidence of wound leakage and an increased length of stay after total joint replacement. Bone Joint J 96-B:122\u2013126","DOI":"10.1302\/0301-620X.96B1.31569"},{"key":"3622_CR7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-physiol-012110-142305","volume":"73","author":"Bovill","year":"2011","unstructured":"Bovill EG, Vliet A van der (2011) Venous valvular stasis-associated hypoxia and thrombosis: what is the link? Annu Rev Physiol 73:527\u2013545","journal-title":"Annu Rev Physiol"},{"key":"3622_CR8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.arth.2009.06.021","volume":"25","author":"Bozic","year":"2010","unstructured":"Bozic KJ, Vail TP, Pekow PS et al (2010) Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? J Arthroplasty 25:1053\u20131060","journal-title":"J Arthroplasty"},{"key":"3622_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1538-7836.2009.03498.x","volume":"8","author":"Braekkan","year":"2009","unstructured":"Braekkan SK, Mathiesen EB, Njolstad I et al (2009) Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J Thromb Haemost 8:157\u2013162","journal-title":"J Thromb Haemost"},{"key":"3622_CR10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","volume":"367","author":"Brighton","year":"2012","unstructured":"Brighton TA, Eikelboom JW, Mann K et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979\u20131987","journal-title":"N Engl J Med"},{"key":"3622_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.arth.2009.06.002","volume":"24","author":"Brown","year":"2009","unstructured":"Brown GA (2009) Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials. J Arthroplasty 24:77\u201383","journal-title":"J Arthroplasty"},{"key":"3622_CR12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/14740338.2014.895321","volume":"13","author":"Brown","year":"2014","unstructured":"Brown R, Lip GY, Gallego P (2014) Dabigatran etexilate for venous thromboembolism: a safety evaluation. Expert Opin Drug Saf 13:639\u2013647","journal-title":"Expert Opin Drug Saf"},{"key":"3622_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.arth.2008.05.018","volume":"23","author":"Callaghan","year":"2008","unstructured":"Callaghan JJ, Warth LC, Hoballah JJ et al (2008) Evaluation of deep venous thrombosis prophylaxis in low-risk patients undergoing total knee arthroplasty. J Arthroplasty 23:20\u201324","journal-title":"J Arthroplasty"},{"key":"3622_CR14","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","volume":"358","author":"Eriksson","year":"2008","unstructured":"Eriksson BI, Borris LC, Friedman RJ et al (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358:2765\u20132775","journal-title":"N Engl J Med"},{"key":"3622_CR15","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1538-7836.2009.03618.x","volume":"7","author":"Gomez-Outes","year":"2009","unstructured":"Gomez-Outes A, Suarez-Gea ML, Blazquez-Perez A et al (2009) Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient? J Thromb Haemost 7:2149\u20132150","journal-title":"J Thromb Haemost"},{"key":"3622_CR16","doi-asserted-by":"crossref","unstructured":"Green D (2009) Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism. Hematology Am Soc Hematol Educ Program 259\u2013266","DOI":"10.1182\/asheducation-2009.1.259"},{"key":"3622_CR17","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1182\/blood.V80.9.2281.bloodjournal8092281","volume":"80","author":"Herbert","year":"1992","unstructured":"Herbert JM, Bernat A, Maffrand JP (1992) Importance of platelets in experimental venous thrombosis in the rat. Blood 80:2281\u20132286","journal-title":"Blood"},{"key":"3622_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1160\/TH13-08-0654","volume":"111","author":"Hull","year":"2014","unstructured":"Hull RD, Liang J, Bergqvist D et al (2014) Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery. A systematic review. Thromb Haemost 111:199\u2013212","journal-title":"Thromb Haemost"},{"key":"3622_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0883-5403(11)00601-2","volume":"27","author":"Intermountain","year":"2012","unstructured":"Intermountain Joint Replacement Center Writing Committee (2012) A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. J Arthroplasty 27:1\u20139","journal-title":"J Arthroplasty"},{"key":"3622_CR20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1302\/0301-620X.94B7.29129","volume":"94","author":"Jameson","year":"2012","unstructured":"Jameson SS, Baker PN, Charman SC et al (2012) The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after knee replacement: a non-randomised comparison using National Joint Registry Data. J Bone Joint Surg Br 94:914\u2013918","journal-title":"J Bone Joint Surg Br"},{"key":"3622_CR21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1302\/2046-3758.35.2000225","volume":"3","author":"Jameson","year":"2014","unstructured":"Jameson SS, Baker PN, Deehan DJ et al (2014) Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement. Bone Joint Res 3:146\u2013149","journal-title":"Bone Joint Res"},{"key":"3622_CR22","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1302\/0301-620X.93B11.27622","volume":"93","author":"Jameson","year":"2011","unstructured":"Jameson SS, Charman SC, Gregg PJ et al (2011) The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry. J Bone Joint Surg Br 93:1465\u20131470","journal-title":"J Bone Joint Surg Br"},{"key":"3622_CR23","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2106\/JBJS.K.00521","volume":"94","author":"Jameson","year":"2014","unstructured":"Jameson SS, Rymaszewska M, Hui AC et al (2014) Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty. J Bone Joint Surg Am 94:1554\u20131558","journal-title":"J Bone Joint Surg Am"},{"key":"3622_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1302\/0301-620X.93B1.24987","volume":"93","author":"Jensen","year":"2011","unstructured":"Jensen CD, Steval A, Partington PF et al (2011) Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study. J Bone Joint Surg Br 93:91\u201395","journal-title":"J Bone Joint Surg Br"},{"key":"3622_CR25","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1056\/NEJMc081524","volume":"359","author":"Lotke","year":"2008","unstructured":"Lotke PA (2008) Rivaroxaban for thromboprophylaxis. N Engl J Med 359:2174 (author reply 2175\u20132176)","journal-title":"N Engl J Med"},{"key":"3622_CR26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-0038-1653784","volume":"73","author":"Monreal","year":"1995","unstructured":"Monreal M, Lafoz E, Roca J et al (1995) Platelet count, antiplatelet therapy and pulmonary embolism \u2013 a prospective study in patients with hip surgery. Thromb Haemost 73:380\u2013385","journal-title":"Thromb Haemost"},{"key":"3622_CR27","unstructured":"NICE (2010) NICE Clinical guidelines 92: venous thromboembolism: reducing the risk, 2010. http:\/\/www.nice.org.uk\/guidance\/cg92. Zugegriffen: 21. Oktober 2014"},{"key":"3622_CR28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archinte.1989.00390040013003","volume":"149","author":"Powers","year":"1989","unstructured":"Powers PJ, Gent M, Jay RM et al (1989) A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 149:771\u2013774","journal-title":"Arch Intern Med"},{"key":"3622_CR29","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","volume":"355","author":"Pulmonary","year":"2000","unstructured":"Pulmonary Embolism Prevention (PEP) trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 355:1295\u20131302","journal-title":"Lancet"},{"key":"3622_CR30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11999-013-3135-z","volume":"472","author":"Raphael","year":"2014","unstructured":"Raphael IJ, Tischler EH, Huang R et al (2014) Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty? Clin Orthop Relat Res 472:482\u2013488","journal-title":"Clin Orthop Relat Res"},{"key":"3622_CR31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1160\/TH11-04-0275","volume":"106","author":"Rosenkranz","year":"2011","unstructured":"Rosenkranz AC, Schror K, Rauch BH (2011) Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells. Thromb Haemost 106:561\u2013562","journal-title":"Thromb Haemost"},{"key":"3622_CR32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40265-013-0082-7","volume":"73","author":"Sardar","year":"2013","unstructured":"Sardar P, Chatterjee S, Mukherjee D (2013) Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials. Drugs 73:1171\u20131182","journal-title":"Drugs"},{"key":"3622_CR33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/bjs.1800610812","volume":"61","author":"Sevitt","year":"1974","unstructured":"Sevitt S (1974) Organization of valve pocket thrombi and the anomalies of double thrombi and valve cusp involvement. Br J Surg 61:641\u2013649","journal-title":"Br J Surg"},{"key":"3622_CR34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s11999-007-0092-4","volume":"466","author":"Sharrock","year":"2008","unstructured":"Sharrock NE, Gonzalez Della Valle A, Go G et al (2008) Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res 466:714\u2013721","journal-title":"Clin Orthop Relat Res"},{"key":"3622_CR35","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/CIRCULATIONAHA.114.008828","volume":"130","author":"Simes","year":"2014","unstructured":"Simes J, Becattini C, Agnelli G et al (2014) Aspirin for the prevention of recurrent venous thromboembolism: The INSPIRE Collaboration. Circulation 130 (13):1062\u20131071","journal-title":"Circulation"},{"key":"3622_CR36","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1345\/aph.1R331","volume":"47","author":"Stewart","year":"2013","unstructured":"Stewart DW, Freshour JE (2013) Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence. Ann Pharmacother 47:63\u201374","journal-title":"Ann Pharmacother"},{"key":"3622_CR37","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1160\/TH10-10-0683","volume":"105","author":"Turpie","year":"2011","unstructured":"Turpie AG, Esmon C (2011) Venous and arterial thrombosis \u2013 pathogenesis and the rationale for anticoagulation. Thromb Haemost 105:586\u2013596","journal-title":"Thromb Haemost"},{"key":"3622_CR38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","volume":"209","author":"Br\u00fchl","year":"2012","unstructured":"Br\u00fchl ML von, Stark K, Steinhart A et al (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819\u2013835","journal-title":"J Exp Med"},{"key":"3622_CR39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.114.012235","volume":"130","author":"Wakefield","year":"2014","unstructured":"Wakefield TW, Obi AT, Henke PK (2014) An aspirin a day to keep the clots away: can aspirin prevent recurrent thrombosis in extended treatment for venous thromboembolism? Circulation 130:1031\u20131033","journal-title":"Circulation"},{"key":"3622_CR40","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMe1211480","volume":"367","author":"Warkentin","year":"2012","unstructured":"Warkentin TE (2012) Aspirin for dual prevention of venous and arterial thrombosis. N Engl J Med 367:2039\u20132041","journal-title":"N Engl J Med"},{"key":"3622_CR41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.arth.2006.05.017","volume":"21","author":"Westrich","year":"2006","unstructured":"Westrich GH, Bottner F, Windsor RE et al (2006) VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty 21:139\u2013143","journal-title":"J Arthroplasty"},{"key":"3622_CR42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1160\/TH08-07-0493","volume":"101","author":"Wolowacz","year":"2009","unstructured":"Wolowacz SE, Roskell NS, Plumb JM et al (2009) Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost 101:77\u201385","journal-title":"Thromb Haemost"},{"key":"3622_CR43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/MBC.0000000000000121","volume":"25","author":"Zou","year":"2014","unstructured":"Zou Y, Tian S, Wang Y et al (2014) Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis 25:660\u2013664","journal-title":"Blood Coagul Fibrinolysis"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-014-3622-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-014-3622-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-014-3622-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T20:38:41Z","timestamp":1598647121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-014-3622-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3622"],"URL":"https:\/\/doi.org\/10.1007\/s00108-014-3622-7","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}